Bayer Schering’s Xarelto most innovative drug of 2010
Bayer Schering Pharma’s Xarelto for the treatment of venous thromboembolism has won the 2010 UK Prix Galien Innovative Product Award. The drug, which fought off stiff competition from five other products, including AstraZeneca’s Iressa and Merck Serono’s Erbitux, could herald the disappearance of warfarin clinics in the UK.
Read More
